Pfizer (PFE) is close to a $7.3B takeover of Metsera, planning to pay the company $47.50 per share in cash and an additional $22.50 if certain milestones are met, Oliver Barnes of The Financial Times reports, citing two people familiar with the matter. The acquisition could be announced as early as Monday, the sources added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- M&A News: Metsera Stock (MTSR) Rallies over 50% as Pfizer Nears $7.3B Takeover
- CDC panel votes against requiring prescriptions for Covid shots, Bloomberg says
- Pfizer, BioNTech express dedication to making safe Covid vaccines
- CDC panel votes to end universal Covid vaccine recommendation, Bloomberg says
- Mixed options sentiment in Pfizer with shares up 0.48%